For example, aggressive fibromatosis (a fibroblastic/myofibroblastic tumor) is characterized by diffuse cytoplasmic and nuclear β-catenin positivity along with vimentin and Ki-67 expression (31). Here, MKI67 is linked to fibromatosis.